Sumeet Mody

Stock Analyst at Piper Sandler

(4.8)
# 145
Out of 5,438 analysts
54
Total ratings
Success rate
Average return
13 Stocks
Name Action PT Current % Upside Ratings Updated
ENFN Enfusion
Maintains: Neutral
10 12
10.76 6.88% 4 Dec 23, 2024
SEIC SEI Inv
Maintains: Neutral
58 66
87.47 -24.55% 4 Dec 20, 2023
GCMG GCM Grosvenor
Maintains: Overweight
9 10
12.9 -22.48% 2 Aug 10, 2023
KKR KKR & Co
Maintains: Overweight
59 70
141.59 -50.56% 4 Aug 8, 2023
BX Blackstone
Maintains: Overweight
107 115
170.12 -32.4% 7 Jul 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
21 13
10.04 29.48% 1 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
17 15
19.75 -24.05% 3 May 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
35 38
70.94 -46.43% 6 Apr 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
248 260
190.16 36.73% 11 Mar 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
21 23
16.21 41.89% 5 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
86 97
186.69 -48.04% 2 Feb 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
58 48
62.39 -23.06% 1 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
55 58
38.99 48.76% 4 May 2, 2022